A detailed history of Monterey Private Wealth, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Monterey Private Wealth, Inc. holds 2,968 shares of NVO stock, worth $406,616. This represents 0.16% of its overall portfolio holdings.

Number of Shares
2,968
Previous 2,968 -0.0%
Holding current value
$406,616
Previous $381,000 11.02%
% of portfolio
0.16%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

SELL
$102.11 - $135.92 $510 - $679
-5 Reduced 0.17%
2,968 $381,000
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $5,881 - $7,065
67 Added 2.31%
2,973 $307,000
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $132,135 - $289,931
1,453 Added 100.0%
2,906 $264,000
Q1 2023

Apr 06, 2023

BUY
$132.34 - $159.14 $192,290 - $231,230
1,453 New
1,453 $231,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $309B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Monterey Private Wealth, Inc. Portfolio

Follow Monterey Private Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monterey Private Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Monterey Private Wealth, Inc. with notifications on news.